Showing 981 - 1,000 results of 82,552 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( a d decrease ))', query time: 1.23s Refine Results
  1. 981
  2. 982
  3. 983

    TMEM16A knockdown decreased activation of the MEK-ERK1/2 pathway and expression of cyclin D1. by Yujie Sui (549090)

    Published 2014
    “…<p>Western blot results show inhibition of TMEM16A led to a decrease in phospho-MEK, phospho-ERK1/2 and cyclin D1. …”
  4. 984
  5. 985

    Means for STEM competence for pre- and post-test. by Esther Kim (2996622)

    Published 2024
    “…After the Challenge, participants increased in awareness of global issues, and engagement with others, but also showed a small but significant decrease in respect for people from other cultural backgrounds. …”
  6. 986

    Metformin lotion decreases collagen III levels in the wounded skin of rats after 10 days of wound healing. by Jianying Zhang (256508)

    Published 2024
    “…In contrast, wounds treated with 0% ML exhibited higher levels of collagen III expression compared to the 6% ML-treated wounds (<b>A-D</b>). Semi-quantification results are in agreement with these findings (<b>I</b>). …”
  7. 987
  8. 988

    Vitamin D₃ Supplementation in Batswana Children and Adults with HIV: A Pilot Double Blind Randomized Controlled Trial by Andrew P. Steenhoff (199381)

    Published 2015
    “…HAZ and CD4% increased and VL decreased in the 7000IU/d group (p<0.04). Younger (5–13y) and older (30–50y) subjects had greater Δ25D than those 14–29y (26±17 and 28±12 vs. 11±11ng/ml, respectively, p≤0.001). …”
  9. 989

    In vitro characterization of MAb-1D8 activity. by Nanae Nagata (3916574)

    Published 2017
    “…<p>(A) MAb-1D8-mediated inhibition of 0.5 nM [<sup>3</sup>H]PGD<sub>2</sub> binding to mDP2 (B and C) Effects of MAb-1D8 on cAMP-production detected by CRE-mediated luciferase activity in mDP2- and CRE-expressing CHO cells. …”
  10. 990
  11. 991
  12. 992

    S1 File - by Chantelle M. de Vet (16535257)

    Published 2024
    “…The student’s RV-GLS consistency was poor during the first 25 measurements, moderate-to good during the second 25 measurements and again poor-to-moderate during the final 50 measurements. Repeated measurements analysis showed a significant decrease in variability of the LV- and RV-GLS score differences between the expert and trainees over time (<i>p</i><sub>adj</sub><0.001), which was not significantly different between trainees. …”
  13. 993
  14. 994
  15. 995
  16. 996
  17. 997
  18. 998
  19. 999

    High-throughput drug screen reveals HDAC and proteasome inhibitors as potent drug classes against synovial sarcoma. by Aimée N. Laporte (3617987)

    Published 2017
    “…Total score across the six cell lines was calculated out of 6. (D) IC<sub>50</sub> measurements were calculated for drug screen hits quisinostat (HDAC inhibitor), BGT-226 (PI3K/mTOR inhibitor), bortezomib (proteasome inhibitor) as compared with the current standard for synovial sarcoma treatment doxorubicin (cytotoxic DNA/RNA intercalating agent and topoisomerase inhibitor), in a panel of six human SS18-SSX positive cell lines and two control cell lines (HEK293T, MCF7). …”
  20. 1000